Alanna Sedgwick

Alanna Sedgwick currently serves as a Principal Scientist in Toxicology at Vividion Therapeutics, Inc., contributing to immunology and oncology programs through the development of fit-for-purpose assays and conducting target safety assessments. Prior experience includes a Principal Scientist role in Investigative Toxicology at Pfizer, where Alanna developed cell-based toxicology assays across various therapeutic areas and served as a liaison on the Cancer Immunology Discovery Therapeutic Area Leadership Team. At Capricor Therapeutics, Inc., responsibilities involved optimizing mRNA and exosome-based biologics, while a decade at the University of Notre Dame included postdoctoral research in cell proliferation and tumor dynamics. Alanna holds a PhD in Cell & Molecular Biology from the University of Notre Dame and a Bachelor's degree in Biology from California State University-Sacramento.